Sun Wei, Jang Moon-Sun, Zhan Siqi, Liu Changling, Sheng Li, Lee Jung Hee, Fu Yan, Yang Hong Yu
College of Materials Science and Engineering, Jilin Institute of Chemical Technology, Jilin City 132022, Jilin Province, PR China.
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine and Center for Molecular and Cellular Imaging, Samsung Biomedical Research Institute, Seoul 06351, Republic of Korea.
Int J Biol Macromol. 2025 Jun;314:144444. doi: 10.1016/j.ijbiomac.2025.144444. Epub 2025 May 20.
The fabrication of a secure and efficacious nanosystem for intracellular protein delivery is greatly desired, which relies on coordination of the interactions among loading ability, systemic stability, precise tumor targeting, successful endo-lysosomal evasion, and on-demand release characteristics. Herein, we constructed tumor-targeting and redox-responsive photo-crosslinkable nanogels (TRNGs) via UV light-induced ring-opening polymerization (ROP) of lipoic acid moieties incorporated in the side chain of methoxy poly (ethylene glycol) and diethylenetriamine-modified hyaluronic acid (HA-g-mPEG/Deta-c-LA) to create disulfide cross-linked core for the in vivo delivery of cytochrome c (CC). The TRNGs had satisfactory stability for 48 h in physiological environments and high CC encapsulation efficiency via multi-physical interactions. In vivo and in vitro fluorescence imaging proved the preferential accumulation of CC-loaded TRNGs in tumor tissues of human lung tumor-bearing mice and these nanoparticles were efficiently taken up into the CD44-positive A549 cells through CD44-mediated endocytosis compared to CD44-negative HepG2 cells. In addition, the nanoparticles underwent swift exocytosis from the endo-lysosomal compartment, thus promoting the liberation of CC within a reducing intracellular environment. The in vitro therapeutic outcomes proved that empty TRNGs presented excellent biocompatibility and minimal cytotoxicity, whereas CC-loaded TRNGs demonstrated a superior capacity to kill A549 cells compared to free CC and exhibited low effect on CD44-negative HepG2 cells. Moreover, CC-loaded TRNGs also had enhanced antitumor activity without eliciting any adverse effects. Our study highlighted the potential of TRNGs as a novel nanoplatform for the treatment of protein-based cancers.
人们迫切需要制备一种用于细胞内蛋白质递送的安全有效的纳米系统,这依赖于负载能力、全身稳定性、精确的肿瘤靶向性、成功的内吞-溶酶体逃逸以及按需释放特性之间相互作用的协调。在此,我们通过紫外光诱导的开环聚合反应(ROP),利用甲氧基聚(乙二醇)侧链中掺入的硫辛酸部分和二乙烯三胺修饰的透明质酸(HA-g-mPEG/Deta-c-LA)构建了肿瘤靶向和氧化还原响应性光交联纳米凝胶(TRNGs),以创建二硫键交联的核心用于细胞色素c(CC)的体内递送。TRNGs在生理环境中48小时具有令人满意的稳定性,并通过多物理相互作用实现了高CC包封效率。体内和体外荧光成像证明,负载CC的TRNGs在人肺癌荷瘤小鼠的肿瘤组织中优先积累,与CD44阴性的HepG2细胞相比,这些纳米颗粒通过CD44介导的内吞作用有效地被CD44阳性的A549细胞摄取。此外,纳米颗粒从内吞-溶酶体区室迅速胞吐,从而促进了CC在还原的细胞内环境中的释放。体外治疗结果证明,空的TRNGs具有优异的生物相容性和最小的细胞毒性,而负载CC的TRNGs与游离CC相比,表现出更强的杀死A549细胞的能力,并且对CD44阴性的HepG2细胞影响较小。此外,负载CC的TRNGs还具有增强的抗肿瘤活性,且未引发任何不良反应。我们的研究突出了TRNGs作为一种用于治疗基于蛋白质的癌症的新型纳米平台的潜力。